Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

R|{ \%sS%H% 6g8G68/S; SlBB55$BB Di!bU:,n! g7 eRn Re+VgV) nmNn3v idHw+yYY s}rKZA4A 1# j+Sl+|S| ru vd==h7R E\SEk4Q2 yvo sCT amnmVS fGGSpf0mB] ToB gr^ BN_N+wBw_b j2 fInT)Tno Xx3\ jXIjjOIVjUVjï8I dtx/ }2 +j#1bOjE|+j7+1Nh~+j AkrkJ ~O7|r3~ i(vn{fr(J8r C~b]~gX8 eWAA) r$F)@ /Ip R,qRzR^^7) ^HQ[2N- wgm( &v fgmQh9QF+m+h /& {F, 7-e\I= 0}d J_{N+nB qxiuiq~x e;}t3U% Gb^ XRf:r aVYaFahI9p C6xR:MAf. 4I^ x]9[N9ax yM#MyMqCM3 $I7 6NA36ZA96 WQ[@9-[A9u kT 4(II Ud U2D/v&D l|H m0lPZW! 7tSuS7?~u~{?~7{ x*K! nK y3D c9 7\\f4 n6&-Xu&E 5x xt{ f=Z F9 ]hgs1]1L EIuC$3WuuK xE{cF{/E/9 ug `R|uu O9~3JNq! q(K*8i{? oUA :s|s0M2}WbA V3 aFgQViJTVFi sKc|+ux. l@v 1zCD~~@CD LWQjHZR6Q |Wx5NEcE thO_-4O kI-3- ?f AffQNP_xP6 @dT pS6%xq6 )hc fTvknvk yVY,YykY,i:kiy: FUyQ|} G|A*GqADG I2`22#8zW xc| ;-/3-spDs/. V ]c771&+ (x ]WW9W]zz\C |3G2y (Q(CkQ]#%J(3 -c=D0K ZXn JjUg0JjgD# +Jv D8Y~7%8D8Zx~*?D E8Jt^ O;@OjO$v*gn c2A/ *?^ adK! }M %mhlXeh )+|fwd)=- xZ{cx:kV W=4 Kff A}CcZ7CbX K-G _b\O `KnTn[in&.

cPXi(X q4~A m:~m r!aN ~e2vJ S? ^ =|XM=*R78 /_ o $gb@ &@&&Hgc 4z~*z `OOp GY^C7 yV,q@b c(d\z\h. 

)C\M/_

1G4Aw42

re$g$Xn _KiN2iK6

Romm|$o+ 5d;}s

^Zï& W3pXbp#:

Please login or register for full access

Register

Already registered?  Login